S.H. Rosenberg
Impact in
- Hematology top 10%
- Platelet Disorders and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Cancer therapeutics and mechanisms 2
- Receptor Mechanisms and Signaling 2
-
- Renin-Angiotensin System Studies 4
- Co-authors
- Steven W. Elmore (1 shared paper)Ryan M. Fryer (1 shared paper)S. J. Morgan (1 shared paper)Glenn A. Reinhart (1 shared paper)Morey L. Smith (1 shared paper)Lee C. Preusser (1 shared paper)Paul Nimmer (1 shared paper)Randy Nelson (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Clinical Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
S.H. Rosenberg
11 papers receiving 577 citations
Peers
Comparison fields: 5 of 74
- Hematology 140
- Genetics 74
- Oncology 182
- Molecular Biology 356
- Cancer Research 60
Countries citing papers authored by S.H. Rosenberg
This map shows the geographic impact of S.H. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.H. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.H. Rosenberg more than expected).
Fields of papers citing papers by S.H. Rosenberg
This network shows the impact of papers produced by S.H. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.H. Rosenberg. The network helps show where S.H. Rosenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside S.H. Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 335 | |
| 2 | A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. | 2001 | 60 |
| 3 | 2000 | 43 | |
| 4 | 2004 | 38 | |
| 5 | Retinoblastoma. The relationship of proliferating cells to blood vessels. | 1990 | 38 |
| 6 | 1999 | 37 | |
| 7 | 1988 | 16 | |
| 8 | 2000 | 10 | |
| 9 | 1990 | 5 | |
| 10 | 2004 | 4 | |
| 11 | 1992 | 2 | |
| 12 | 1990 | 0 |
About S.H. Rosenberg
S.H. Rosenberg is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Cell Biology and Biochemistry, having authored 12 papers that have together received 588 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (4 papers), Cancer therapeutics and mechanisms (2 papers), Receptor Mechanisms and Signaling (2 papers), Microtubule and mitosis dynamics (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Cancer Treatment and Pharmacology (1 paper), Cell Adhesion Molecules Research (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Hematology (140 citations), Genetics (74 citations), Oncology (182 citations), Molecular Biology (356 citations) and Cancer Research (60 citations). S.H. Rosenberg has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Steven W. Elmore, Ryan M. Fryer, S. J. Morgan, Glenn A. Reinhart, Morey L. Smith, Lee C. Preusser, Paul Nimmer, Randy Nelson, Laurie Iciek and Christin Tse. Their work appears in journals such as European Journal of Cancer, Clinical Chemistry, Journal of Pharmacology and Experimental Therapeutics, Cancer Chemotherapy and Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.